O	O	0	5	Cross	Cross	B-NP	NN	O	12	SUB	O
O	O	5	6	-	-	O	HYPH	O	1	P	O
O	O	6	13	linking	link	B-VP	VBG	O	1	NMOD	O
O	O	14	16	of	of	B-PP	IN	O	3	VMOD	O
T1	B-Protein	17	21	CD44	CD44	B-NP	NN	B-protein	4	PMOD	B-protein
O	O	22	24	on	on	B-PP	IN	O	3	VMOD	O
O	O	25	35	rheumatoid	rheumatoid	B-NP	JJ	B-cell_type	9	NMOD	B-cell_type
O	O	36	44	synovial	synovial	I-NP	JJ	I-cell_type	9	NMOD	I-cell_type
O	O	45	50	cells	cell	I-NP	NNS	I-cell_type	6	PMOD	I-cell_type
O	O	51	53	up	up	B-ADVP	RB	O	11	VMOD	O
O	O	53	54	-	-	B-NP	HYPH	O	3	OBJ	O
O	O	54	63	regulates	regulate	B-VP	VBZ	O	0	ROOT	O
T2	B-Protein	64	68	VCAM	VCAM	B-NP	NN	B-protein	14	NMOD	B-protein
T2	I-Protein	68	69	-	-	B-NP	HYPH	I-protein	12	OBJ	I-protein
T2	I-Protein	69	70	1	1	I-NP	CD	I-protein	14	NMOD	I-protein
O	O	70	71	.	.	O	.	O	12	P	O

T3	B-Protein	73	77	CD44	CD44	B-NP	NN	B-protein	2	SUB	B-protein
O	O	78	80	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	81	82	a	a	B-NP	DT	O	5	NMOD	O
O	O	83	93	ubiquitous	ubiquitous	I-NP	JJ	B-protein	5	NMOD	B-protein
O	O	94	102	molecule	molecule	I-NP	NN	I-protein	2	PRD	I-protein
O	O	103	107	also	also	B-VP	RB	O	7	VMOD	O
O	O	108	113	known	know	I-VP	VBN	O	5	NMOD	O
O	O	114	116	as	as	B-PP	IN	O	7	VMOD	O
O	O	117	127	hyaluronic	hyaluronic	B-NP	JJ	O	10	NMOD	O
O	O	128	132	acid	acid	I-NP	NN	O	13	NMOD	O
O	O	133	135	or	or	O	CC	O	13	NMOD	O
O	O	136	142	homing	homing	B-NP	JJ	B-protein	13	NMOD	B-protein
O	O	143	151	receptor	receptor	I-NP	NN	I-protein	8	PMOD	I-protein
O	O	151	152	.	.	O	.	O	2	P	O

O	O	153	160	However	However	B-ADVP	RB	O	18	VMOD	O
O	O	160	161	,	,	O	,	O	18	P	O
O	O	162	165	the	the	B-NP	DT	O	5	NMOD	O
O	O	166	174	cellular	cellular	I-NP	JJ	O	5	NMOD	O
O	O	175	184	functions	function	I-NP	NNS	O	8	NMOD	O
O	O	185	188	and	and	O	CC	O	8	NMOD	O
O	O	189	192	its	its	B-NP	PRP$	O	8	NMOD	O
O	O	193	197	role	role	I-NP	NN	O	18	SUB	O
O	O	198	200	in	in	B-PP	IN	O	8	NMOD	O
O	O	201	213	inflammation	inflammation	B-NP	NN	O	9	PMOD	O
O	O	213	214	,	,	O	,	O	18	P	O
O	O	215	218	for	for	B-PP	IN	O	18	VMOD	O
O	O	219	226	example	example	B-NP	NN	O	12	PMOD	O
O	O	226	227	,	,	O	,	O	18	P	O
O	O	228	238	rheumatoid	rheumatoid	B-NP	JJ	O	16	NMOD	O
O	O	239	248	synovitis	synovitis	I-NP	NN	O	18	SUB	O
O	O	248	249	,	,	O	,	O	16	P	O
O	O	250	253	are	be	B-VP	VBP	O	0	ROOT	O
O	O	254	263	currently	currently	B-ADJP	RB	O	18	VMOD	O
O	O	264	271	unknown	unknown	I-ADJP	JJ	O	18	PRD	O
O	O	271	272	.	.	O	.	O	18	P	O

O	O	273	275	In	In	B-PP	IN	O	6	VMOD	O
O	O	276	280	this	this	B-NP	DT	O	3	NMOD	O
O	O	281	286	study	study	I-NP	NN	O	1	PMOD	O
O	O	286	287	,	,	O	,	O	6	P	O
O	O	288	290	we	we	B-NP	PRP	O	6	SUB	O
O	O	291	298	propose	propose	B-VP	VBP	O	0	ROOT	O
O	O	299	300	a	a	B-NP	DT	O	9	NMOD	O
O	O	301	306	novel	novel	I-NP	JJ	O	9	NMOD	O
O	O	307	315	function	function	I-NP	NN	O	6	OBJ	O
O	O	316	319	for	for	B-PP	IN	O	9	NMOD	O
T4	B-Protein	320	324	CD44	CD44	B-NP	NN	B-protein	10	PMOD	B-protein
O	O	324	325	.	.	O	.	O	6	P	O

O	O	326	331	Using	Use	B-VP	VBG	O	13	VMOD	O
O	O	332	340	synovial	synovial	B-NP	JJ	B-cell_type	3	NMOD	B-cell_type
O	O	341	346	cells	cell	I-NP	NNS	I-cell_type	1	OBJ	I-cell_type
O	O	347	351	from	from	B-PP	IN	O	1	VMOD	O
O	O	352	362	rheumatoid	rheumatoid	B-NP	JJ	O	6	NMOD	O
O	O	363	372	arthritis	arthritis	I-NP	NN	O	10	NMOD	O
O	O	373	374	(	(	O	(	O	9	DEP	O
O	O	374	376	RA	RA	B-NP	NN	O	9	DEP	O
O	O	376	377	)	)	O	)	O	6	NMOD	O
O	O	378	386	patients	patient	B-NP	NNS	O	4	PMOD	O
O	O	386	387	,	,	O	,	O	13	P	O
O	O	388	390	we	we	B-NP	PRP	O	13	SUB	O
O	O	391	403	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT	O
O	O	404	408	that	that	B-SBAR	IN	O	13	VMOD	O
T5	B-Protein	409	413	CD44	CD44	B-NP	NN	B-protein	23	SUB	B-protein
O	O	414	419	cross	cross	O	AFX	O	15	NMOD	O
O	O	419	420	-	-	O	HYPH	O	16	AMOD	O
O	O	420	427	linking	link	B-VP	VBG	O	17	NMOD	O
O	O	428	431	and	and	I-VP	CC	O	18	VMOD	O
O	O	432	439	binding	bind	I-VP	VBG	O	18	VMOD	O
O	O	440	442	to	to	B-PP	TO	O	20	NMOD	O
O	O	443	453	hyaluronan	hyaluronan	B-NP	NN	O	21	PMOD	O
O	O	454	463	augmented	augment	B-VP	VBD	O	14	SBAR	O
T6	B-Protein	464	468	VCAM	VCAM	B-NP	NN	B-protein	27	NMOD	B-protein
T6	I-Protein	468	469	-	-	O	HYPH	I-protein	27	NMOD	I-protein
T6	I-Protein	469	470	1	1	B-NP	CD	I-protein	27	NMOD	I-protein
O	O	471	481	expression	expression	I-NP	NN	O	23	OBJ	O
O	O	482	485	and	and	O	CC	O	23	VMOD	O
O	O	486	498	subsequently	subsequently	B-ADVP	RB	O	23	VMOD	O
T7	B-Protein	499	503	VCAM	VCAM	B-NP	NN	B-protein	36	NMOD	B-protein
T7	I-Protein	503	504	-	-	B-NP	HYPH	I-protein	32	P	I-protein
T7	I-Protein	504	505	1	1	I-NP	CD	I-protein	30	NMOD	I-protein
O	O	505	506	-	-	I-NP	HYPH	O	30	P	O
O	O	506	514	mediated	mediate	I-NP	VBN	O	36	NMOD	O
O	O	515	519	cell	cell	I-NP	NN	O	36	NMOD	O
O	O	520	528	adhesion	adhesion	I-NP	NN	O	23	OBJ	O
O	O	528	529	.	.	O	.	O	13	P	O

O	O	530	537	Briefly	Briefly	B-ADVP	RB	O	4	VMOD	O
O	O	537	538	,	,	O	,	O	4	P	O
O	O	539	541	we	we	B-NP	PRP	O	4	SUB	O
O	O	542	547	found	find	B-VP	VBD	O	0	ROOT	O
O	O	548	552	that	that	B-SBAR	IN	O	4	VMOD	O
O	O	553	554	1	1	B-LST	LS	O	10	NMOD	O
O	O	554	555	)	)	O	)	O	6	DEP	O
O	O	556	566	rheumatoid	rheumatoid	B-NP	JJ	B-cell_type	10	NMOD	B-cell_type
O	O	567	575	synovial	synovial	I-NP	JJ	I-cell_type	10	NMOD	I-cell_type
O	O	576	581	cells	cell	I-NP	NNS	I-cell_type	12	SUB	I-cell_type
O	O	582	588	highly	highly	B-ADVP	RB	O	12	VMOD	O
O	O	589	598	expressed	express	B-VP	VBD	O	5	SBAR	O
T8	B-Protein	599	603	CD44	CD44	B-NP	NN	B-protein	12	OBJ	B-protein
O	O	603	604	;	;	O	:	O	12	VMOD	O
O	O	605	606	2	2	B-LST	LS	O	14	ROOT	O
O	O	606	607	)	)	O	)	O	15	DEP	O
O	O	608	613	cross	cross	O	AFX	O	15	DEP	O
O	O	613	614	-	-	O	HYPH	O	19	P	O
O	O	614	621	linking	link	B-VP	VBG	O	17	VMOD	O
O	O	622	624	of	of	B-PP	IN	O	19	VMOD	O
T9	B-Protein	625	629	CD44	CD44	B-NP	NN	B-protein	25	SUB	B-protein
O	O	630	638	markedly	markedly	B-VP	RB	O	25	VMOD	O
O	O	639	642	but	but	I-VP	CC	O	22	AMOD	O
O	O	643	654	transiently	transiently	I-VP	RB	O	22	AMOD	O
O	O	655	664	augmented	augment	I-VP	VBD	O	89	VMOD	O
T10	B-Protein	665	669	VCAM	VCAM	B-NP	NN	B-protein	29	NMOD	B-protein
T10	I-Protein	669	670	-	-	O	HYPH	I-protein	29	NMOD	I-protein
T10	I-Protein	670	671	1	1	B-NP	CD	I-protein	29	NMOD	I-protein
O	O	672	682	expression	expression	I-NP	NN	O	33	NMOD	O
O	O	683	686	and	and	O	CC	O	33	NMOD	O
O	O	687	690	its	its	B-NP	PRP$	O	33	NMOD	O
T20	B-Entity	691	695	mRNA	mRNA	I-NP	NN	B-RNA	33	NMOD	B-RNA
O	O	696	709	transcription	transcription	I-NP	NN	O	37	SUB	O
O	O	710	714	much	much	B-VP	RB	O	37	VMOD	O
O	O	715	719	more	more	I-VP	RBR	O	34	AMOD	O
O	O	720	724	than	than	I-VP	IN	O	34	AMOD	O
O	O	725	728	did	do	I-VP	VBD	O	89	VMOD	O
T11	B-Protein	729	731	IL	IL	B-NP	NN	B-protein	40	NMOD	B-protein
T11	I-Protein	731	732	-	-	B-NP	HYPH	I-protein	40	NMOD	I-protein
T11	I-Protein	732	737	1beta	1beta	I-NP	NN	I-protein	65	SUB	I-protein
O	O	738	741	and	and	I-NP	CC	O	44	NMOD	O
T12	B-Protein	742	745	TNF	TNF	I-NP	NN	B-protein	44	NMOD	B-protein
T12	I-Protein	745	746	-	-	O	HYPH	O	44	P	O
T12	I-Protein	746	751	alpha	alpha	B-NP	SYM	O	65	VMOD	O
O	O	751	752	;	;	O	:	O	65	P	O
O	O	753	754	3	3	B-LST	LS	O	65	VMOD	O
O	O	754	755	)	)	O	)	O	46	DEP	O
O	O	756	766	hyaluronan	hyaluronan	B-NP	NN	O	65	SUB	O
O	O	766	767	,	,	O	,	O	48	P	O
O	O	768	778	especially	especially	B-ADVP	RB	O	51	AMOD	O
O	O	779	783	when	when	B-ADVP	WRB	O	65	VMOD	O
O	O	784	794	fragmented	fragment	B-VP	VBN	O	51	SBAR	O
O	O	794	795	,	,	O	,	O	56	P	O
O	O	796	800	also	also	B-ADVP	RB	O	56	VMOD	O
O	O	801	803	up	up	B-ADVP	RB	O	56	VMOD	O
O	O	803	804	-	-	B-VP	HYPH	O	65	VMOD	O
O	O	804	813	regulated	regulate	B-NP	VBN	O	59	NMOD	O
T13	B-Protein	814	818	VCAM	VCAM	I-NP	NN	B-protein	59	NMOD	B-protein
T13	I-Protein	818	819	-	-	B-NP	HYPH	O	65	VMOD	O
T13	I-Protein	819	820	1	1	I-NP	CD	O	59	NMOD	O
O	O	820	821	;	;	O	:	O	65	P	O
O	O	822	823	4	4	O	CD	O	65	VMOD	O
O	O	823	824	)	)	O	)	O	62	DEP	O
T14	B-Protein	825	829	CD44	CD44	B-NP	NN	B-protein	65	SUB	B-protein
O	O	830	839	activated	activate	B-VP	VBD	O	89	VMOD	O
O	O	840	843	the	the	B-NP	DT	O	68	NMOD	O
O	O	844	857	transcription	transcription	I-NP	NN	B-protein	68	NMOD	B-protein
O	O	858	864	factor	factor	I-NP	NN	I-protein	70	NMOD	I-protein
T15	B-Protein	865	867	AP	AP	I-NP	NN	B-protein	70	NMOD	B-protein
T15	I-Protein	867	868	-	-	B-NP	HYPH	I-protein	65	OBJ	I-protein
T15	I-Protein	868	869	1	1	I-NP	CD	I-protein	70	NMOD	I-protein
O	O	869	870	;	;	O	:	O	89	P	O
O	O	871	874	and	and	O	CC	O	81	NMOD	O
O	O	875	876	5	5	B-LST	LS	O	81	NMOD	O
O	O	876	877	)	)	O	)	O	74	DEP	O
O	O	878	881	the	the	B-NP	DT	O	77	NMOD	O
O	O	882	890	integrin	integrin	I-NP	NN	B-protein	81	NMOD	B-protein
O	O	890	891	-	-	B-NP	HYPH	O	81	NMOD	O
O	O	891	900	dependent	dependent	I-NP	JJ	O	81	NMOD	O
O	O	901	909	adhesive	adhesive	I-NP	JJ	O	81	NMOD	O
O	O	910	918	function	function	I-NP	NN	O	89	SUB	O
O	O	919	921	of	of	B-PP	IN	O	81	NMOD	O
O	O	922	924	RA	RA	B-NP	NN	B-cell_type	85	NMOD	B-cell_type
O	O	925	933	synovial	synovial	I-NP	JJ	I-cell_type	85	NMOD	I-cell_type
O	O	934	939	cells	cell	I-NP	NNS	I-cell_type	82	PMOD	I-cell_type
O	O	940	942	to	to	B-PP	TO	O	81	NMOD	O
O	O	943	944	T	T	B-NP	NN	B-cell_type	88	NMOD	B-cell_type
O	O	945	950	cells	cell	I-NP	NNS	I-cell_type	86	PMOD	I-cell_type
O	O	951	954	was	be	B-VP	VBD	O	20	SBAR	O
O	O	955	959	also	also	I-VP	RB	O	89	VMOD	O
O	O	960	969	amplified	amplify	I-VP	VBN	O	89	VC	O
O	O	970	972	by	by	B-PP	IN	O	91	VMOD	O
T16	B-Protein	973	977	CD44	CD44	B-NP	NN	B-protein	92	PMOD	B-protein
O	O	978	983	cross	cross	O	AFX	O	91	VMOD	O
O	O	983	984	-	-	O	HYPH	O	94	P	O
O	O	984	991	linking	link	B-VP	VBG	O	94	DEP	O
O	O	991	992	.	.	O	.	O	15	P	O

O	O	993	998	These	These	B-NP	DT	O	2	NMOD	O
O	O	999	1006	results	result	I-NP	NNS	O	3	SUB	O
O	O	1007	1015	indicate	indicate	B-VP	VBP	O	0	ROOT	O
O	O	1016	1020	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	1021	1024	the	the	B-NP	DT	O	6	NMOD	O
O	O	1025	1033	adhesion	adhesion	I-NP	NN	O	19	SUB	O
O	O	1034	1036	of	of	B-PP	IN	O	6	NMOD	O
O	O	1037	1039	RA	RA	B-NP	NN	B-cell_type	10	NMOD	B-cell_type
O	O	1040	1048	synovial	synovial	I-NP	JJ	I-cell_type	10	NMOD	I-cell_type
O	O	1049	1054	cells	cell	I-NP	NNS	I-cell_type	7	PMOD	I-cell_type
O	O	1055	1057	to	to	B-PP	TO	O	6	NMOD	O
O	O	1058	1066	matrices	matrix	B-NP	NNS	O	11	PMOD	O
O	O	1067	1071	such	such	B-PP	JJ	O	14	PMOD	O
O	O	1072	1074	as	as	I-PP	IN	O	12	NMOD	O
O	O	1075	1085	hyaluronic	hyaluronic	B-NP	JJ	O	16	NMOD	O
O	O	1086	1090	acid	acid	I-NP	NN	O	14	PMOD	O
O	O	1091	1098	through	through	B-PP	IN	O	6	NMOD	O
T17	B-Protein	1099	1103	CD44	CD44	B-NP	NN	B-protein	17	PMOD	B-protein
O	O	1104	1109	could	could	B-VP	MD	O	4	SBAR	O
O	O	1110	1112	up	up	I-VP	RB	O	21	VMOD	O
O	O	1112	1113	-	-	I-VP	HYPH	O	19	P	O
O	O	1113	1121	regulate	regulate	I-VP	VB	O	19	VC	O
T18	B-Protein	1122	1126	VCAM	VCAM	B-NP	NN	B-protein	26	NMOD	B-protein
T18	I-Protein	1126	1127	-	-	B-NP	HYPH	I-protein	26	NMOD	I-protein
T18	I-Protein	1127	1128	1	1	I-NP	CD	I-protein	26	NMOD	I-protein
O	O	1129	1139	expression	expression	I-NP	NN	O	33	NMOD	O
O	O	1140	1143	and	and	I-NP	CC	O	33	NMOD	O
T19	B-Protein	1144	1148	VCAM	VCAM	I-NP	NN	B-protein	29	NMOD	B-protein
T19	I-Protein	1148	1149	-	-	B-NP	HYPH	I-protein	33	NMOD	I-protein
T19	I-Protein	1149	1150	1	1	I-NP	CD	I-protein	29	NMOD	I-protein
O	O	1150	1151	-	-	I-NP	HYPH	O	29	P	O
O	O	1151	1159	mediated	mediate	I-NP	VBN	O	33	NMOD	O
O	O	1160	1168	adhesion	adhesion	I-NP	NN	O	22	OBJ	O
O	O	1169	1171	to	to	B-PP	TO	O	33	NMOD	O
O	O	1172	1173	T	T	B-NP	NN	B-cell_type	36	NMOD	B-cell_type
O	O	1174	1179	cells	cell	I-NP	NNS	I-cell_type	34	PMOD	I-cell_type
O	O	1179	1180	,	,	O	,	O	33	P	O
O	O	1181	1186	which	which	B-NP	WDT	O	33	NMOD	O
O	O	1187	1192	might	might	B-VP	MD	O	38	SBAR	O
O	O	1193	1195	in	in	B-PP	IN	O	39	VMOD	O
O	O	1196	1200	turn	turn	B-NP	NN	O	40	PMOD	O
O	O	1201	1206	cause	cause	B-VP	VBP	O	19	VC	O
O	O	1207	1217	activation	activation	B-NP	NN	O	42	OBJ	O
O	O	1218	1220	of	of	B-PP	IN	O	43	NMOD	O
O	O	1221	1222	T	T	B-NP	NN	B-cell_type	46	NMOD	B-cell_type
O	O	1223	1228	cells	cell	I-NP	NNS	I-cell_type	49	NMOD	I-cell_type
O	O	1229	1232	and	and	O	CC	O	49	NMOD	O
O	O	1233	1241	synovial	synovial	B-NP	JJ	B-cell_type	49	NMOD	B-cell_type
O	O	1242	1247	cells	cell	I-NP	NNS	I-cell_type	44	PMOD	I-cell_type
O	O	1248	1250	in	in	B-PP	IN	O	43	NMOD	O
O	O	1251	1253	RA	RA	B-NP	NN	O	52	NMOD	O
O	O	1254	1263	synovitis	synovitis	I-NP	NN	O	50	PMOD	O
O	O	1263	1264	.	.	O	.	O	3	P	O

O	O	1265	1267	We	We	B-NP	PRP	O	3	SUB	O
O	O	1268	1277	therefore	therefore	B-ADVP	RB	O	3	VMOD	O
O	O	1278	1285	propose	propose	B-VP	VBP	O	0	ROOT	O
O	O	1286	1290	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	1291	1295	such	such	B-NP	JJ	O	13	SUB	O
O	O	1296	1301	cross	cross	I-NP	AFX	O	5	NMOD	O
O	O	1301	1302	-	-	I-NP	HYPH	O	5	P	O
O	O	1302	1309	talking	talk	B-VP	VBG	O	5	NMOD	O
O	O	1310	1315	among	among	B-PP	IN	O	8	VMOD	O
O	O	1316	1324	distinct	distinct	B-NP	JJ	O	12	NMOD	O
O	O	1325	1333	adhesion	adhesion	I-NP	NN	B-protein	12	NMOD	B-protein
O	O	1334	1343	molecules	molecule	I-NP	NNS	I-protein	9	PMOD	I-protein
O	O	1344	1347	may	may	B-VP	MD	O	4	SBAR	O
O	O	1348	1350	be	be	I-VP	VB	O	13	VC	O
O	O	1351	1359	involved	involve	I-VP	VBN	O	14	VC	O
O	O	1360	1362	in	in	B-PP	IN	O	15	VMOD	O
O	O	1363	1366	the	the	B-NP	DT	O	18	NMOD	O
O	O	1367	1379	pathogenesis	pathogenesis	I-NP	NN	O	16	PMOD	O
O	O	1380	1382	of	of	B-PP	IN	O	18	NMOD	O
O	O	1383	1395	inflammation	inflammation	B-NP	NN	O	19	PMOD	O
O	O	1395	1396	,	,	O	,	O	15	P	O
O	O	1397	1406	including	include	B-PP	VBG	O	15	VMOD	O
O	O	1407	1409	RA	RA	B-NP	NN	O	24	NMOD	O
O	O	1410	1419	synovitis	synovitis	I-NP	NN	O	22	PMOD	O
O	O	1419	1420	.	.	O	.	O	3	P	O
